Creso Pharma: A Truly Global Cannabis Company
Ryan Allway December 5th, 2018 Exclusive, News, Top News The North American cannabis industry is littered with companies touting global ambitions. There are regular announcements regarding letters of intent to distribute in emerging markets like Europe and Latin America, long on potential and short on concrete details. Many... Read more
Canntab Nears Commercialization with Innovative Cannabis Tablets
Ryan Allway November 28th, 2018 Uncategorized The global cannabis industry is projected to reach $146.4 billion by 2025, according to Grand View Research, representing a blistering 34.6 percent compound annual growth rate. With medical and adult-use legalization across a growing number of countries, there’s an enormous opportunity for... Read more
Supreme Cannabis Focused on Disciplined Deployment of Capital
Ryan Allway November 21st, 2018 Exclusive, News, Top News The cannabis industry has boomed in recent years supported by the access to inexpensive capital, which has stemmed from a voracious investor appetite for cannabis exposure and the prospects of outsized returns. In turn, many licensed producers have quickly... Read more
Aleafia Health to Launch Global Cannabis Education Platform with D2L
Platform to Provide Cannabis Education Courses TORONTO, Nov. 14, 2018 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSXV: ALEF: OTCQX: ALEAF, FRA: ARAH) (“Aleafia”) has entered into a global agreement with D2L (Desire2Learn) Corporation (“D2L“), in which Aleafia Health will deploy D2L’s Learning Management System (LMS) Brightspace. Brightspace is a cloud-based... Read more
Lexaria Targets Cannabinoids, Tobacco, Hemp, and Pharma Markets with New Subsidiaries
Ryan Allway November 13th, 2018 Exclusive, News, Top News The cannabis industry is projected to generation hundreds of billions of dollars of revenue over the coming years, driven by the legalization of medical and recreational cannabis across North America. While many investors are focused on cultivation or dispensary... Read more
48North Cannabis Corp. Acquires Good & Green for Next Generation Cannabis Products
Ryan Allway November 8th, 2018 Exclusive, News, Press Releases, Top News In late October of this 2018, 48North Cannabis Corp. (TSX-V: NRTH) entered into a binding letter agreement to acquire all issued and outstanding common shares of privately-held Good & Green, a socially-responsible, organic cannabis brand. Combined with... Read more
Pascal Biosciences Announces Optimization of Cannabinoid-Derived Drug Candidates to Kill Glioblastoma Cells
Ryan Allway November 5th, 2018 News, Press Releases VANCOUVER, British Columbia and SEATTLE, Nov. 05, 2018 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced the peer reviewed publication and upcoming presentation of their recently licensed cannabinoid-derived drug... Read more
High Hampton Signs LOI to Acquire California Extracts Manufacturer
Ryan Allway November 2nd, 2018 Uncategorized The cannabis industry is projected to reach $75 billion by 2030, according to Cowen & Co., driven by the legalization of medical and recreational cannabis across a growing number of states. According to Arcview Market Research and BDS Analytics, a large portion... Read more
FSD Pharma Doubles Down on Cannabinoid Therapeutics with Therapix Acquisition
Ryan Allway October 26th, 2018 Exclusive, Feature Stories, News Canada’s cannabis industry could experience a dramatic windfall with the legalization of recreational cannabis in October, but many cannabis companies are looking beyond the borders for opportunities. In particular, the most progressive cannabis companies are building up both their... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )